889 assets in Neoplasm

Therapeutic assets addressing Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Max-40279-01 Neoplasm	Maxinovel Pty., Ltd.	P1	C (36)
Mem-288 Intratumoral Neoplasm	Memgen, Inc.	P1	C (36)
Micvotabart Neoplasm	Pyxis Oncology, Inc	P1	C (36)
mq719 Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (36)
Mrtx0902 Neoplasm	Mirati Therapeutics Inc.	P1	C (36)
Mrtx1133 Neoplasm	Mirati Therapeutics Inc.	P1	C (36)
Mrtx1719 Neoplasm	M.D. Anderson Cancer Center	P1	C (36)
Msk-Tcr5 Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (36)
Neoantigen Mrna Personalised Cancer Sw1115C3 Neoplasm	Stemirna Therapeutics	P1	C (36)
Neo-T Neoplasm	BGI, China	P1	C (36)
Nerofe Neoplasm	Georgetown University	P1	C (36)
nib101 Neoplasm	Noile-Immune Biotech, Inc	P1	C (36)
nkt3447 Neoplasm	NiKang Therapeutics, Inc.	P1	C (36)
nkt3964 Neoplasm	NiKang Therapeutics, Inc.	P1	C (36)
np-101 Neoplasm	M.D. Anderson Cancer Center	P1	C (36)
Oberotatug Ravtansine Neoplasm	Oxford BioTherapeutics Ltd	P1	C (36)
Oct-598 Neoplasm	Oscotec Inc.	P1	C (36)
Ono-4538 Neoplasm	Ono Pharmaceutical Co., Ltd.	P1	C (36)
Ono-7428 Neoplasm	Ono Pharmaceutical Co., Ltd.	P1	C (36)
Ono-7914 Neoplasm	Ono Pharmaceutical Co., Ltd.	P1	C (36)
Ot-A201 Neoplasm	Onward Therapeutics	P1	C (36)
pb101 Neoplasm	Panolos Bioscience	P1	C (36)
Pimurutamab Neoplasm	Shanghai Henlius Biotech	P1	C (36)
PIN Neoplasm	Chinese PLA General Hospital	P1	C (36)
pt0253 Neoplasm	PAQ Therapeutics, Inc.	P1	C (36)
pt0511 Neoplasm	PAQ Therapeutics, Inc.	P1	C (36)
Ptx-912 Neoplasm	Proviva Therapeutics, Inc.	P1	C (36)
qlf31907 Neoplasm	Qilu Pharmaceutical Co., Ltd.	P1	C (36)
QN302 Neoplasm	Qualigen Theraputics, Inc.	P1	C (36)
r-5780 Neoplasm	Rise Therapeutics LLC	P1	C (36)
Radvax Neoplasm	Vaxine Pty Ltd	P1	C (36)
Rose12 Neoplasm	Chugai Pharmaceutical	P1	C (36)
ryz401 Neoplasm	RayzeBio, Inc.	P1	C (36)
sb17170 Neoplasm	SPARK Biopharma	P1	C (36)
Scr-6920 Neoplasm	Jiangsu Simcere Pharmaceutical Co., Ltd.	P1	C (36)
Setidegrasib Neoplasm	Astellas Pharma Inc	P1	C (36)
Shr-A1811 For Neoplasm	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1	C (36)
Si-B036 Neoplasm	Sichuan Baili Pharmaceutical Co., Ltd.	P1	C (36)
Son-Dp Neoplasm	Qurgen Inc.	P1	C (36)
Spx-303 Neoplasm	SparX Biotech(Jiangsu) Co., Ltd.	P1	C (36)
Sti-1386 Neoplasm	Sorrento Therapeutics, Inc.	P1	C (36)
STP707 Neoplasm	Sirnaomics	P1	C (36)
stp938 Neoplasm	Step Pharma, SAS	P1	C (36)
sv-101 Neoplasm	Williams Cancer Foundation	P1	C (36)
Tach101 Neoplasm	Tachyon Therapeutics, Inc.	P1	C (36)
tas2940 Neoplasm	Taiho Oncology, Inc.	P1	C (36)
TH19P01-DOCETAXEL Neoplasm	Theratechnologies	P1	C (36)
tj033721 Neoplasm	I-Mab Biopharma US Limited	P1	C (36)
Tolododekin Alfa Neoplasm	Ankyra Therapeutics, Inc	P1	C (36)
tqb3811 Neoplasm	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P1	C (36)

Showing 751 to 800 of 889 assets

PreviousPage 16 of 18Next